These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38810606)

  • 1. Transcription Factor E2F8 Activates PDK1-Mediated DNA Damage Repair to Enhance Cisplatin Resistance in Lung Adenocarcinoma.
    Li H; Sun J; Hu H; Wang Y
    Pharmacology; 2024 May; 109(6):341-356. PubMed ID: 38810606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-195-5p inhibits cisplatin resistance in lung adenocarcinoma by regulating DNA damage via targeting E2F7.
    Wu H; Zheng B
    J Biochem Mol Toxicol; 2024 Nov; 38(11):e70015. PubMed ID: 39415701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-486-5p Regulates DNA Damage Inhibition and Cisplatin Resistance in Lung Adenocarcinoma by Targeting AURKB.
    Sun G; Ni K; Shen J; Liu D; Wang H
    Crit Rev Eukaryot Gene Expr; 2024; 34(4):13-23. PubMed ID: 38505869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.
    Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM
    Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma.
    Ai C; Huang Z; Rong T; Shen W; Yang F; Li Q; Bi L; Li W
    Electrophoresis; 2024 Aug; 45(15-16):1408-1417. PubMed ID: 38629299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1-3p affects lung adenocarcinoma progression through E2F8 and regulating NF-кB pathway.
    Lin Q
    Cytokine; 2022 Aug; 156():155922. PubMed ID: 35660716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3.
    Wang T; Zhu X; Wang K; Li J; Hu X; Lin P; Zhang J
    Pulm Pharmacol Ther; 2023 Jun; 80():102217. PubMed ID: 37121465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinoma.
    Liu K; Wang L; Lou Z; Guo L; Xu Y; Qi H; Fang Z; Mei L; Chen X; Zhang X; Shao J; Xiang X
    Biochem Pharmacol; 2023 Dec; 218():115854. PubMed ID: 37863324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription Factor E2F8 Promotes Cisplatin Resistance in Hepatocellular Carcinoma by Regulating DNA Damage via NUSAP1.
    Kong J; Xu S; Zhang P; Wang Y
    Int J Toxicol; 2023; 42(5):420-429. PubMed ID: 37331996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a competing endogenous RNA axis "SVIL-AS1/miR-103a/ICE1" associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis.
    Guo L; Ding L; Tang J
    Cancer Med; 2021 Sep; 10(17):6022-6034. PubMed ID: 34264003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDP Induced Cytotoxicity through miR-215-5p/COL5A1/FSTL1 Axis to Regulate Autophagy in Lung Adenocarcinoma Cells.
    Zhao X; Zhang H; Gu L; Zhang H; Cao H
    Curr Pharm Biotechnol; 2024 Sep; ():. PubMed ID: 39289933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.
    Liu G; Liu X; Zeng W; Zhou W
    Pharmacology; 2024; 109(4):202-215. PubMed ID: 38643755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.
    Gong L; Xiao M; He D; Hu Y; Zhu Y; Xiang L; Bao Y; Liu X; Zeng Q; Liu J; Zhou M; Zhou Y; Cheng Y; Zhang Y; Deng L; Zhu R; Lan H; Cao K
    Front Oncol; 2020; 10():461. PubMed ID: 32426268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
    Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
    Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation.
    Gong L; Hu Y; He D; Zhu Y; Xiang L; Xiao M; Bao Y; Liu X; Zeng Q; Liu J; Zhou M; Zhou Y; Cheng Y; Zhang Y; Deng L; Zhu R; Lan H; Cao K
    Cancer Cell Int; 2020; 20():194. PubMed ID: 32508530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription Factor ETV4 Activates AURKA to Promote PD-L1 Expression and Mediate Immune Escape in Lung Adenocarcinoma.
    Yang P; He S; Ye L; Weng H
    Int Arch Allergy Immunol; 2024; 185(9):910-920. PubMed ID: 38781935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
    Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F
    Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer.
    Liu X; Yin Z; Wu Y; Zhan Q; Huang H; Fan J
    Bioengineered; 2022 Feb; 13(2):3739-3750. PubMed ID: 35081867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.